CATEGORIES

Future Medicine India

Covid-19: India To Vaccinate All Above 18

The central government has started vaccination for everyone above the age of 18 from May 1, 2021.

time-read
10+ mins  |
May 2021
“OUR CALL TO COUNTRIES IS TO DO BI-DIRECTIONAL TESTING FOR TB AND COVID-19”
Future Medicine India

“OUR CALL TO COUNTRIES IS TO DO BI-DIRECTIONAL TESTING FOR TB AND COVID-19”

DR LUCICA DITIU is the Executive Director of Stop TB Partnership— one of the most influential advocacy voices on global health and tuberculosis that provides support for a TB response to achieve a world without TB. A specialist in lung diseases from Romania, Dr Ditiu started her international career with the WHO in January 2000 as a medical officer for TB in Albania, Kosovo and FYR Macedonia within the disaster and preparedness unit. She has worked for the past 18 years with WHO and the UN system at every level: national, sub-regional, regional and global. At the helm of the Stop TB Partnership for the past eight years, Dr Ditiu has been relentless in pushing for the inclusion of everyone affected by TB. In an interaction with S HARACHAND, she speaks about the international body’s ambitious goal to make the world free of the curable infectious disease and how the programme has been impacted by various challenges, including the COVID-19 pandemic.

time-read
10 mins  |
May 2021
Viloxazine for treatment of ADHD
Future Medicine India

Viloxazine for treatment of ADHD

Supernus Pharmaceuticals announced that the US FDA approved viloxazine extended-release capsules (Qelbree) for the treatment of attention-deficit hyperactivity disorder (ADHD) in paediatric patients 6 to 17 years of age.

time-read
10+ mins  |
May 2021
SECNIDAZOLE SHOWS HIGHER CURE RATES IN TRICHOMONIASIS
Future Medicine India

SECNIDAZOLE SHOWS HIGHER CURE RATES IN TRICHOMONIASIS

The use of antibiotic secnidazole was found to be effective in treating women with trichomoniasis, according to a recent phase 3 study now published in the journal Clinical Infectious Diseases.

time-read
3 mins  |
May 2021
Future Medicine India

DOCS RUE VIP CULTURE IN GOVT HOSPITALS

Politicians and bureaucrats without severe illness demand preferential treatment, causing great hardship to the overstrained frontline, say doctors

time-read
3 mins  |
May 2021
Future Medicine India

VACCINE BREAKTHROUGHS

Virus variants in the spotlight as number of reinfections and breakthroughs rise

time-read
10+ mins  |
May 2021
CONVALESCENT PLASMA TREATMENT GUIDELINES
Future Medicine India

CONVALESCENT PLASMA TREATMENT GUIDELINES

Plasma from donors who have recovered from COVID-19 may contain antibodies to SARS-CoV-2 that may help suppress the virus and modify the inflammatory response.1 The Food and Drug Administration (FDA) issued an Emergency Use Authorisation (EUA) for convalescent plasma for the treatment of certain hospitalised patients with COVID-19.

time-read
7 mins  |
May 2021
SHOULD A DOCTOR PAY FOR MRs?
Future Medicine India

SHOULD A DOCTOR PAY FOR MRs?

Paid consultation from the pharma field force could run into several challenges

time-read
4 mins  |
May 2021
ANTI-SARS-COV-2 MONOCLONAL ANTIBODIES TREATMENT GUIDELINES
Future Medicine India

ANTI-SARS-COV-2 MONOCLONAL ANTIBODIES TREATMENT GUIDELINES

The SARS-CoV-2 genome encodes four major structural proteins: spike (S), envelope (E), membrane (M), and nucleocapsid (N), as well as nonstructural and accessory proteins. The S protein is further divided into two subunits, S1 and S2, that mediate host cell attachment and invasion. Through its receptor-binding domain (RBD), S1 attaches to angiotensin-converting enzyme 2 (ACE2) on the host cell; this initiates a conformational change in S2 resulting in virus-host cell membrane fusion and viral entry.

time-read
10 mins  |
May 2021
Docs Raise Concern Over Vaccine Safety
Future Medicine India

Docs Raise Concern Over Vaccine Safety

Even as IMA endorses the safety of Indian vaccines, a section of doctors fears the “inadequately tested” COVID shots

time-read
6 mins  |
February 2021
Covid-19 Triggers Accelerated Investment In AI, Nanotech
Future Medicine India

Covid-19 Triggers Accelerated Investment In AI, Nanotech

Economic forecasts say the fallout from COVID-19 is driving huge investment within AI and nanotechnology

time-read
5 mins  |
February 2021
India's elderly population to cross 319m by 2050: LASI report
Future Medicine India

India's elderly population to cross 319m by 2050: LASI report

The elderly population in India is poised to rise three-fold from ten years ago to the level of over 319 million by 2050, according to the Longitudinal Ageing Study of India.

time-read
1 min  |
February 2021
VACCINATION CONSIDERATIONS FOR PEOPLE WHO ARE PREGNANT OR BREASTFEEDING
Future Medicine India

VACCINATION CONSIDERATIONS FOR PEOPLE WHO ARE PREGNANT OR BREASTFEEDING

CDC and the independent Advisory Committee on Immunization Practices (ACIP) have provided information to assist pregnant people with their decision to receive the COVID-19 vaccine.

time-read
4 mins  |
February 2021
PAMDA AWARDS 2021 - HOLISTIC HEALER
Future Medicine India

PAMDA AWARDS 2021 - HOLISTIC HEALER

Dr BELLE MONAPPA HEGDE Recipient of Padma Vibhushan, 2021

time-read
2 mins  |
February 2021
People have option to receive or reject Covaxin: Bharat Bio
Future Medicine India

People have option to receive or reject Covaxin: Bharat Bio

Individuals offered to receive Covaxin will have the option to receive or reject administration of the vaccine, according to a fact sheet issued by Bharat Biotech.

time-read
1 min  |
February 2021
UNION BUDGET 2021 - INDIA HIKES HEALTHCARE SPEND BY 137%
Future Medicine India

UNION BUDGET 2021 - INDIA HIKES HEALTHCARE SPEND BY 137%

Allocates Rs 35,000 cr for COVID-19 vaccination

time-read
3 mins  |
February 2021
RUSSIAN SPUTNIK V VACCINE GETS EUAs IN UAE, HUNGARY
Future Medicine India

RUSSIAN SPUTNIK V VACCINE GETS EUAs IN UAE, HUNGARY

The UAE Ministry of Health and Prevention (MOHAP) has authorized the use of Russian Sputnik V vaccine, the Russian Direct Investment Fund (RDIF) has announced.

time-read
1 min  |
February 2021
CHRONICLING COVID-19
Future Medicine India

CHRONICLING COVID-19

Covid-19: What You Need to Know About the Coronavirus and the Race for the Vaccine by Dr Michael Mosley is one of the most comprehensive compilations on COVID-19 and SARS-CoV-2, the virus behind the pandemic.

time-read
2 mins  |
February 2021
A TREASURE TROVE OF THERAPEUTICS?
Future Medicine India

A TREASURE TROVE OF THERAPEUTICS?

Cyanobacteria remain largely unutilised despite these microorganisms’ huge potential as drug sources

time-read
5 mins  |
February 2021
Hijacking Coagulation Using Platelets
Future Medicine India

Hijacking Coagulation Using Platelets

One-third of COVID-19 patients in ICUs develop thrombotic complications leading to high morbidity

time-read
5 mins  |
January 2021
SHIGELLA SCARE IN KERALA
Future Medicine India

SHIGELLA SCARE IN KERALA

The southern Indian state is on high alert following an outbreak of shigellosis

time-read
2 mins  |
January 2021
PATHOLOGY-TAUGHT-IN-INDIA-HAS-VERY-LITTLE-EMPHASIS-ON-CLINICAL-REASONING-AND-APPLICATION
Future Medicine India

PATHOLOGY-TAUGHT-IN-INDIA-HAS-VERY-LITTLE-EMPHASIS-ON-CLINICAL-REASONING-AND-APPLICATION

Pathology is an area that has witnessed the most transformative changes due to the advent of new technology, especially in precision medicine. While this has helped pathologists to constantly update their knowledge and toolkit, it has also raised the diagnostic burden in labs across the world. For instance, newly emerged molecular pathology helps pathologists study a set of markers on each patient and predict which therapy will be most beneficial for each of them. Telepathology service enables any pathologist in any corner of the world to beam images to a specialist.

time-read
7 mins  |
January 2021
NCDs ARE LEADING CAUSES OF DEATH AND DISABILITY: WHO
Future Medicine India

NCDs ARE LEADING CAUSES OF DEATH AND DISABILITY: WHO

Heart disease is now killing more people than ever before

time-read
4 mins  |
January 2021
VACCINE SAFETY IS ALWAYS A MATTER OF RISKS AND BENEFITS, BUT TECH ADVANCES HELP REDUCE THE RISK: EXPERTS
Future Medicine India

VACCINE SAFETY IS ALWAYS A MATTER OF RISKS AND BENEFITS, BUT TECH ADVANCES HELP REDUCE THE RISK: EXPERTS

The FM December webinar delved into concerns around the safety and efficacy of rapidly-developed COVID-19 vaccines authorised for emergency use

time-read
3 mins  |
January 2021
A World Without Aids: Still A Distant Dream
Future Medicine India

A World Without Aids: Still A Distant Dream

Nearly four decades later, HIV continues to elude a cure and defies all efforts to wipe it out

time-read
8 mins  |
December 2020
Covid-19: Behind The Scenes Genetics
Future Medicine India

Covid-19: Behind The Scenes Genetics

Individual genetics plays crucial in determining COVID-19 treatment outcomes

time-read
9 mins  |
December 2020
A Long Journey Ahead With Covid-19
Future Medicine India

A Long Journey Ahead With Covid-19

The long-term effects of COVID-19 in low-risk individuals need to be studied urgently

time-read
3 mins  |
December 2020
“FEAR, ANGER AND COMFORT DRIVE PATIENTS TO SOCIAL MEDIA”
Future Medicine India

“FEAR, ANGER AND COMFORT DRIVE PATIENTS TO SOCIAL MEDIA”

Fake news has always been a problem in the media sector. But never has it been as big a challenge as it is in the current social media era, especially on the topics of health and pharmaceuticals.

time-read
5 mins  |
December 2020
India reserves mbbS seats for ‘Wards of cOVID Warriors'
Future Medicine India

India reserves mbbS seats for ‘Wards of cOVID Warriors'

The Indian government has decided to introduce a new category called ‘Wards of COVID Warriors’ in the guidelines for selection and nomination of candidates against Central Pool MBBS seats for the academic year 2020-21.

time-read
1 min  |
December 2020
INDIAN STUDY FLAGS PRKAG2-LINKED HCM IN SOUTH ASIA
Future Medicine India

INDIAN STUDY FLAGS PRKAG2-LINKED HCM IN SOUTH ASIA

Study finds clinical and genetic features of cardiomyopathy reported from multiple large familial cases in India

time-read
4 mins  |
December 2020